The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with Illumina, Inc. for an annual preventive care maintenance plan for the Illumina NexSeq 1000 Sequencer under the Silver Support Plan. This procurement is essential for ensuring the operational functionality and repair of the sequencer, which is critical for conducting microbiome research and various genomic analyses within the NIAID Microbiome Program. The contract will cover comprehensive services including parts, labor, remote technical support, and on-site applications support, with a performance period from October 28, 2024, to October 27, 2025. Interested vendors may submit capability statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by October 22, 2024, at 5:00 PM ET, with all submissions requiring prior registration in the eSASS system. For further inquiries, contact Dana Monroe at dana.monroe@nih.gov or call 406-375-9814.